Glucocorticoid Long-term Administration: Effect on Cold Induced Energy Expenditure and Resting Me⦠(NCT03949361) | Clinical Trial Compass
CompletedNot Applicable
Glucocorticoid Long-term Administration: Effect on Cold Induced Energy Expenditure and Resting Metabolic Rate
Switzerland7 participantsStarted 2019-06-01
Plain-language summary
The aim of the study is to investigate whether treatment with glucocorticoids leads to a change in heat production of the human body at mild cold conditions.
Who can participate
Age range18 Years ā 75 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Planned therapy with at least 7.5 mg prednisone equivalent per day or higher for more than 28 days (group A)
* Planned weaning off glucocorticoid therapy which lasted al least 28 days with a dosage of at least 7.5 mg prednisone (group B)
* BMI 19-30 kg/m2
* Informed Consent as documented by signature
Exclusion Criteria:
* Insufficient thyroid hormone substitution in case of hypothyroidism
* Uncontrolled diabetes mellitus (HbA1c \>7.5%)
* Severe concomitant diseases: chronic heart failure, liver cirrhosis, kidney failure, active cancer
* Known hypersensitivity to cold, e.g. primary or secondary Raynaud's Syndrome
* Known or suspected non-compliance
* Abuse of alcohol or illicit drugs
* Claustrophobia
* Women who are pregnant or breast feeding
* Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc of the participant
* Previous enrolment into the current study
* Enrolment into another study using ionizing radiation within the previous 12 months
What they're measuring
1
Cold-induced thermogenesis (CIT) under glucocorticoids
Timeframe: Change from glucocortoid start to +4 to 8 weeks into treatment/ +3 months after weaning off GCs (resp.)